Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5374)
Contineum Therapeutics, Inc. (CTNM)
Stengone Carmine N. — Director
Shares
2,500
Price
$16.46
Total Value
$41.14K
Shares Held After
17,217
% of Holdings
12.7%
Inhibrx Biosciences, Inc. (INBX)
Kayyem Jon Faiz — Director
Shares
5,000
Price
$113.52
Total Value
$567.58K
Shares Held After
424,360
% of Holdings
1.2%
Dyne Therapeutics, Inc. (DYN)
Friedl-Naderer Johanna — Chief Commercial Officer
Shares
185
Price
$18.88
Total Value
$3.49K
Shares Held After
152,897
% of Holdings
0.1%
Dyne Therapeutics, Inc. (DYN)
Kerr Douglas — Chief Medical Officer
Shares
1,290
Price
$18.88
Total Value
$24.36K
Shares Held After
162,564
% of Holdings
0.8%
Dyne Therapeutics, Inc. (DYN)
Cox John — Director
Shares
5,658
Price
$18.88
Total Value
$106.82K
Shares Held After
357,507
% of Holdings
1.6%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research&Development
Shares
3,500
Price
$75.46
Total Value
$264.11K
Shares Held After
153,902
% of Holdings
2.2%
Inhibrx Biosciences, Inc. (INBX)
FORSYTH DOUGLAS — Director
Shares
2,500
Price
$114.65
Total Value
$286.62K
Shares Held After
227,064
% of Holdings
1.1%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
9,681
Price
$112.28
Total Value
$1.09M
Shares Held After
730,548
% of Holdings
1.3%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
1,219
Price
$111.88
Total Value
$136.38K
Shares Held After
720,867
% of Holdings
0.2%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
500
Price
$108.23
Total Value
$54.12K
Shares Held After
719,648
% of Holdings
0.1%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
1,100
Price
$107.12
Total Value
$117.84K
Shares Held After
719,148
% of Holdings
0.2%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
6,605
Price
$100.64
Total Value
$664.72K
Shares Held After
718,048
% of Holdings
0.9%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
5,895
Price
$99.29
Total Value
$585.34K
Shares Held After
711,443
% of Holdings
0.8%
Telix Pharmaceuticals Ltd (TLX)
Smith Darren Charlton — Group Chief Financial Officer
Shares
2,071
Price
$9.66
Total Value
$20.00K
Shares Held After
13,992
% of Holdings
14.8%
KAMADA LTD (KMDA)
Tsur David — Director
Shares
14,238
Price
$8.28
Total Value
$117.89K
Shares Held After
593,691
% of Holdings
2.3%
CYBIN INC. (CYBN)
So Eric H. L. — Director
Shares
100,000
Price
$12.09
Total Value
$1.21M
Shares Held After
4,365,014
% of Holdings
2.3%
SS Innovations International, Inc. (SSII)
Sudhir Srivastava — Director
Shares
33,333
Price
$3.00
Total Value
$100.00K
Shares Held After
108,520,928
% of Holdings
0.0%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
220,070
Price
$11.17
Total Value
$2.46M
Shares Held After
2,073,558
% of Holdings
10.6%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
220,070
Price
$11.17
Total Value
$2.46M
Shares Held After
4,711,801
% of Holdings
4.7%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
8,111
Price
$193.13
Total Value
$1.57M
Shares Held After
96,134
% of Holdings
7.8%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
4,209
Price
$192.54
Total Value
$810.41K
Shares Held After
104,245
% of Holdings
3.9%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
11,080
Price
$191.15
Total Value
$2.12M
Shares Held After
108,454
% of Holdings
9.3%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
600
Price
$190.39
Total Value
$114.23K
Shares Held After
119,534
% of Holdings
0.5%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
8,955
Price
$189.34
Total Value
$1.70M
Shares Held After
120,134
% of Holdings
6.9%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
3,045
Price
$188.26
Total Value
$573.25K
Shares Held After
129,089
% of Holdings
2.3%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
6,200
Price
$187.25
Total Value
$1.16M
Shares Held After
132,134
% of Holdings
4.5%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
7,800
Price
$186.32
Total Value
$1.45M
Shares Held After
138,334
% of Holdings
5.3%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
4,593
Price
$185.34
Total Value
$851.29K
Shares Held After
146,134
% of Holdings
3.0%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
6,252
Price
$184.52
Total Value
$1.15M
Shares Held After
150,727
% of Holdings
4.0%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
4,955
Price
$183.30
Total Value
$908.23K
Shares Held After
156,979
% of Holdings
3.1%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
3,413
Price
$182.50
Total Value
$622.87K
Shares Held After
161,934
% of Holdings
2.1%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
2,587
Price
$181.24
Total Value
$468.88K
Shares Held After
165,347
% of Holdings
1.5%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
2,635
Price
$180.29
Total Value
$475.07K
Shares Held After
167,934
% of Holdings
1.5%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
4,602
Price
$193.12
Total Value
$888.73K
Shares Held After
44,000
% of Holdings
9.5%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
3,398
Price
$192.40
Total Value
$653.79K
Shares Held After
48,602
% of Holdings
6.5%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
6,200
Price
$191.09
Total Value
$1.18M
Shares Held After
52,000
% of Holdings
10.7%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
1,800
Price
$190.63
Total Value
$343.14K
Shares Held After
58,200
% of Holdings
3.0%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
6,200
Price
$189.22
Total Value
$1.17M
Shares Held After
60,000
% of Holdings
9.4%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
1,900
Price
$188.59
Total Value
$358.32K
Shares Held After
66,200
% of Holdings
2.8%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
3,900
Price
$187.16
Total Value
$729.94K
Shares Held After
68,100
% of Holdings
5.4%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
4,600
Price
$186.34
Total Value
$857.19K
Shares Held After
72,000
% of Holdings
6.0%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
3,872
Price
$185.28
Total Value
$717.41K
Shares Held After
76,600
% of Holdings
4.8%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
3,569
Price
$184.57
Total Value
$658.74K
Shares Held After
80,472
% of Holdings
4.2%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
3,759
Price
$183.27
Total Value
$688.90K
Shares Held After
84,041
% of Holdings
4.3%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
2,000
Price
$182.49
Total Value
$364.99K
Shares Held After
87,800
% of Holdings
2.2%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
2,000
Price
$181.05
Total Value
$362.11K
Shares Held After
89,800
% of Holdings
2.2%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
1,633
Price
$180.16
Total Value
$294.20K
Shares Held After
91,800
% of Holdings
1.7%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
2,100
Price
$68.98
Total Value
$144.86K
Shares Held After
529,918
% of Holdings
0.4%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
918
Price
$69.52
Total Value
$63.82K
Shares Held After
527,818
% of Holdings
0.2%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
38,500
Price
$7.11
Total Value
$273.74K
Shares Held After
4,106,452
% of Holdings
0.9%
Showing 501–550 of 5374 transactions (page 11 of 108)